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Pancreatic cancer is the deadliest form of cancer having the lowest 5-year relative survival rate (˂ 5%). It 
ranks as the seventh leading cause of cancer-related deaths worldwide. Surgery, chemotherapy and 
radiotherapy are used to extend survival and/or relieve pancreatic cancer patients’ symptoms. However, for 
advanced stage pancreatic cancer cases, there is still no treatment. The aggressiveness of pancreatic cancer 
and the unavailability of definite treatment was further complicated due to the absence of appropriate screening 
tests and diagnostic markers for its early detection. Therefore, there is an urgent need for finding an effective 
treatment for this disease. 
Cells in tumor microenvironment suffers from hypoxia and nutrition starvation due to the insufficient blood 
supply and excessive energy demand of intensively proliferating cells. For most cancer types, a process of 
angiogenesis takes place in order to sustain oxygen and nutrients supply. Despite the hypovascular nature of 
pancreatic tumors, pancreatic cancer cells have the remarkable ability to survive under metabolic stress 
conditions. Such phenomenon is referred to as “austerity”. The search of agents that inhibit cancer cells 
tolerance to nutrition starvation is a new approach for the anticancer drug discovery. 
In the present study, extracts of Anneslea fragrans Wall., Betula alnoides, and Artemisia vulgaris showed 
preferential cytotoxicity against the PANC-1 human pancreatic cancer cells under nutrient-deprived 
conditions. Therefore, the phytochemical investigation of these active extracts was carried out in order to 
identify the active constituents responsible for the observed preferential cytotoxic activities. 
Chemical constituents of Anneslea fragrans and their antiausterity activity against the 
PANC-1 human pancreatic cancer cell line  
Anneslea fragrans Wall. (Theaceae) is a tree native to Southeast Asia. Traditionally, the leaves and bark of 
this plant are used to treat fever, diarrhea and liver inflammation. Leaves and twigs of this plant were collected 
from the Chiang Mai Province of Thailand, and showed preferential cytotoxicity against the PANC-1 cancer 
cells under a nutrient-deprived condition with a PC50 value of 9.6 and 16.4 µg/mL, respectively.   
The phytochemical investigation of the leaves of A. fragrans resulted in the isolation of a new 
dihydrochalcone glucoside named fragranone A (1), and a new chalcone, fragranone B (2), together with 
fifteen previously reported compounds (Chart 1). Fragranone A (1) represents the first example of a rare natural 
product bearing an acetonide glucose moiety. Absolute configuration of the sugar unit in 1 was confirmed 
through acid catalyzed hydrolysis followed by extracting the sugar part and comparing its specific optical 
rotation with that reported for D-glucose. Both values are in very close agreement which confirmed the 
absolute configuration of the sugar part in 1 as D-glucose. Fragranone B (2) is representative of a rare class of 
natural products with a threonolactone unit linked to chalcone through an ether linkage. 1D NOE experiments 
and applying axial haloketone rule to the experimental ECD spectrum of 2, in addition to computational ECD 
calculations were used to unequivocally confirm the absolute configuration of the lactone unit in 2 as 
L-threono-1,4-lactone.1
The phytochemical investigation of the twigs of A. fragrans resulted in the isolation of an unprecedented
flavanoid trimer named fragranol A (18), two new highly oxygenated spiro-biflavanoids named fragranols B 
and C (19 and 20), and a new dihydrochalcone glucoside, fragranone C (21), together with seven previously 
reported compounds (Chart 2). Fragranol A (18) represents a new class of structurally challenging and 
sterically hindered "spiro-triflavanoid" compounds possessing an unprecedented carbon skeleton. Compound 
18 consists of a unique 45 carbon skeleton having six stereocenters, including two unprecedented spiro-chiral 
centers. Fragranols B and C (19 and 20) are the first spiro-biflavanoids incorporating a 2S,3R-flavan-3-ol unit. 
Extensive NMR spectroscopic analysis, taking consideration of the in-depth spatial anisotropic effects around 
spiro-centers, in addition to quantum computational ECD calculations have been employed for deciphering 
the absolute configuration of the chiral centers in fragranols A−C (18-20).2-4   
All isolated compounds were tested for preferential cytotoxicity against PANC-1 human pancreatic cancer 
cell line utilizing the antiausterity strategy. Many compounds exhibited antiausterity activity against PANC-1 
cells, and betulin (14) was found to be the most potent compound tested with a PC50 value of 8.4 μM. In 
addition, fragranone A (1) was found to suppress PANC-1 cancer cell migration in real time.1  
Chemical constituents of Betula alnoides and their antiausterity activity against the PANC-1 
human pancreatic cancer cell line  
The 95% ethanolic extract of B. alnoides Ham. ex D. Don (Betulaceae) bark, collected from the Chiang Rai 
Province of Thailand, showed preferential cytotoxicity against the PANC-1 human pancreatic cancer cells 
under a nutrient-deprived condition with a PC50 value of 13.2 µg/mL. Phytochemical investigation of this 
active extract led to the isolation of six new benzophenones (27−32), together with five known compounds. 
The new compounds 27−31 incorporate open-sesquiterpene side chains. The new benzophenone 32 consists 
of a benzo[c]-2-oxadicyclo[3.3.1]nonane tricyclic system. The new compounds displayed potent antiausterity 
activity against PANC-1 cells in nutrient-deprived medium, without showing toxicity in normal, nutrient-rich 
conditions. Moreover, 27 and 32 induced alterations in PANC-1 cell morphology under nutrient-deprived 
conditions and also inhibited PANC-1 colony formation under nutrient-rich conditions.5  
Chemical constituents of Artemisia vulgaris and their antiausterity activity against the 
PANC-1 human pancreatic cancer cell line  
The genus Artemisia is one of the most diverse and widely distributed genera of Asteraceae family with over 
500 species distributed in Europe, Asia, and North America. Ever since the discovery of the potent antimalarial 
agent artemisinin from Artemisia annua in 1972, a considerable focus has been made on finding new 
compounds with promising therapeutic activity from this genus. As such, several compounds with diverse 
biological activities have been reported. 
In the present study, the 70% ethanolic extract of A. vulgaris showed preferential cytotoxicity against the 
PANC-1 cells under a nutrient-deprived medium (NDM) with a PC50 value of 12.5 µg/mL. The phytochemical 
investigation of this active extract resulted in the isolation of a new sesquiterpene named vulgaric acid (37), 
together with eight previously reported compounds (Chart 3). The structural elucidation of 37 was achieved 
by HRFABMS and NMR analysis. The absolute configuration of 37 was determined by computational 
calculations of ECD data. All isolated compounds were tested for preferential cytotoxicity against PANC-1 
cells, and apigenin (39) showed the strongest activity with a PC50 value of 30.7 μM.
6 
Conclusion 
Phytochemical investigation of the extracts A. fragrans, B. alnoides and  A. vulgaris led to the isolation of 
44 compounds including two new dihydrochalcones (1 and 21), a new chalcone (2), one unprecedented spiro-
triflavanoid (18), two structurally challenging spiro-biflavanoids (19 and 20), six rare benzophenones (27−32) 
and a new sesquiterpene (37). Betulin (14) from A. fragrans and compounds 26−32 from B. alnoides showed 
potent preferential cytotoxicity against PANC-1 cells. Fragranone A (1) was found to suppress PANC-1 cancer 
cell migration in real time. Moreover, compounds 27 and 32 induced alterations in PANC-1 cell morphology 
under nutrient-deprived conditions and also inhibited PANC-1 colony formation under nutrient-rich 
conditions. In conclusion, in the present study, secondary metabolites isolated from the three selected 
Southeast Asian medicinal plants are interesting candidates for drug development against pancreatic cancer. 
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Chart 1. Structures of compounds isolated from A. fragrans leaves 
Figure 1. Most stable conformer of 2 (optimized at 
the B3LYP/6-31G* level) showing hydrogen bonds 
(dashed green lines), and key NOESY correlations 
(blue arrows) observed for 2.
Figure 2. Experimental and calculated ECD 
spectra for 2. 
Red color = new compounds 
Figure 3. Fragranone A (1) suppresses the migration 
of PANC-1 cells in a wound-healing assay in real time. 
Chart 2. Structures of compounds isolated from A. fragrans twigs 
 
 
 
Figure 4. Minumum structure (optimized at the 
DFT-B3LYP/def2-SVP level) of 18, with the key 
NOESY correlations (blue arrows). 
Figure 5. Experimental and calculated ECD 
spectra for 18. 
Red color = new compounds 
Chart 3. Structures of compounds isolated from B. alnoides 
Figure 6. Connectivity (bold blue lines) deduced by 
COSY and HMQC and significant HMBC 
correlations (red arrows) in 27 and 31. 
Figure 7. Experimental and calculated ECD 
spectra for 27 and 31. 
27 
31 
Red color = new compounds 
Chart 4. Structures of compounds isolated from A. vulgaris 
no. PC50, µM
a no. PC50, µM no. PC50, µM no. PC50, µM no. PC50, µM 
1 60.9 9 21.8 26   8.3 34 61.0 41  73.9 
3 10.5 11 17.4 28, 29   8.4 36 45.2 43  41.8 
4 82.6 14   8.4 30 12.3 37 67.7 others >100
5 10.4 15 58.1 31   6.7 38 87.5 arctigeninb  0.7 
7 67.0 16 14.7 32   5.5 39 30.7 
8   8.9 17 26.9 33 42.5 40 57.6 
a Concentration at which 50% of cells were killed preferentially in NDM.  bPositive control. 
Figure 8. Connectivity (bold blue lines) deduced by 
COSY and HMQC and significant HMBC 
correlations (red arrows) in 37. 
Figure 9. Experimental and calculated ECD 
spectra for 37. 
Red color = new compounds 
Table 1. Preferential Cytotoxicity (PC50) of Compounds 1−44 against the PANC-1 Human Pancreatic 
 Cancer Cell Line in Nutrient-Deprived Medium (NDM). 


